300858 科拓生物
已收盘 09-10 15:00:00
资讯
新帖
简况
科拓生物（300858）2026年中报简析：增收不增利，三费占比上升明显
证券之星 · 08-25
科拓生物（300858）2026年中报简析：增收不增利，三费占比上升明显
8月24日科拓生物跌5.52%，招商均衡配置混合A基金重仓该股
证券之星 · 08-24
8月24日科拓生物跌5.52%，招商均衡配置混合A基金重仓该股
科拓生物2026年半年报：双轮驱动营收增长，增收不增利且现金流承压
蓝鲸财经 · 08-24
科拓生物2026年半年报：双轮驱动营收增长，增收不增利且现金流承压
图解科拓生物中报：第二季度单季净利润同比下降51.40%
证券之星 · 08-23
图解科拓生物中报：第二季度单季净利润同比下降51.40%
科拓生物(300858)6月30日股东户数1.75万户，较上期减少11.38%
证券之星 · 08-23
科拓生物(300858)6月30日股东户数1.75万户，较上期减少11.38%
科拓生物：关于对巴彦淖尔市圣牧高科生态草业有限公司投资的出资额及性质等具体情况，请关注公司将于2026年8月24日在巨潮资讯网披露的2026年半年度报告
证券之星 · 08-18
科拓生物：关于对巴彦淖尔市圣牧高科生态草业有限公司投资的出资额及性质等具体情况，请关注公司将于2026年8月24日在巨潮资讯网披露的2026年半年度报告
科拓生物（300858）披露回购公司股份进展公告，8月4日股价上涨0.64%
证券之星 · 08-04
科拓生物（300858）披露回购公司股份进展公告，8月4日股价上涨0.64%
7月17日科拓生物跌5.21%，工银消费服务混合A基金重仓该股
证券之星 · 07-17
7月17日科拓生物跌5.21%，工银消费服务混合A基金重仓该股
科拓生物（300858）披露2025年年度权益分派实施后调整回购股份价格上限的公告，7月9日股价下跌1.4%
证券之星 · 07-09
科拓生物（300858）披露2025年年度权益分派实施后调整回购股份价格上限的公告，7月9日股价下跌1.4%
科拓生物（300858）披露回购公司股份的进展公告，7月2日股价下跌0.58%
证券之星 · 07-02
科拓生物（300858）披露回购公司股份的进展公告，7月2日股价下跌0.58%
科拓生物（300858）披露回购公司股份比例达到1%的进展公告，6月30日股价下跌0.65%
证券之星 · 06-30
科拓生物（300858）披露回购公司股份比例达到1%的进展公告，6月30日股价下跌0.65%
6月29日科拓生物涨7.37%，工银消费服务混合A基金重仓该股
证券之星 · 06-29
6月29日科拓生物涨7.37%，工银消费服务混合A基金重仓该股
科拓生物（300858）披露回购公司股份进展公告，6月3日股价下跌0.25%
证券之星 · 06-03
科拓生物（300858）披露回购公司股份进展公告，6月3日股价下跌0.25%
科拓生物：呼和浩特益生菌智慧工厂I期项目投运
证券之星 · 06-03
科拓生物：呼和浩特益生菌智慧工厂I期项目投运
科拓生物：公司主营业务为食用益生菌制品、动植物微生态制剂以及复配食品添加剂的研发、生产与销售
证券之星 · 06-03
科拓生物：公司主营业务为食用益生菌制品、动植物微生态制剂以及复配食品添加剂的研发、生产与销售
科拓生物：公司益生菌ProSci-246已应用至公司即食型益生菌产品中
证券之星 · 06-03
科拓生物：公司益生菌ProSci-246已应用至公司即食型益生菌产品中
科拓生物（300858）披露2025年年度股东会决议公告，5月21日股价下跌1.14%
证券之星 · 05-21
科拓生物（300858）披露2025年年度股东会决议公告，5月21日股价下跌1.14%
5月8日科拓生物涨5.20%，工银消费服务混合A基金重仓该股
证券之星 · 05-08
5月8日科拓生物涨5.20%，工银消费服务混合A基金重仓该股
4月27日科拓生物跌8.11%，工银消费服务混合A基金重仓该股
证券之星 · 04-27
4月27日科拓生物跌8.11%，工银消费服务混合A基金重仓该股
4月24日科拓生物跌8.34%，工银消费服务混合A基金重仓该股
证券之星 · 04-24
4月24日科拓生物跌8.34%，工银消费服务混合A基金重仓该股
加载更多
公司概况
公司名称：
北京科拓恒通生物技术股份有限公司
所属行业：
食品制造业
上市日期：
2020-07-27
主营业务：
北京科拓恒通生物技术股份有限公司的主营业务是食用益生菌制品、动植物微生态制剂以及复配食品添加剂研发、生产与销售。公司的主要产品是食用益生菌制品、动植物微生态制剂、复配食品添加剂。公司参与的《优良乳酸菌种质资源挖掘与产业化关键技术创制及应用》项目，荣获2023年度国家科学技术进步奖二等奖。
发行价格：
23.70
{"stockData":{"symbol":"300858","market":"SZ","secType":"STK","nameCN":"科拓生物","latestPrice":14.12,"timestamp":1789023798000,"preClose":14.56,"halted":0,"volume":3154550,"delay":0,"changeRate":-0.0302,"floatShares":196000000,"shares":263000000,"eps":0.2976,"marketStatus":"已收盘","change":-0.44,"latestTime":"09-10 15:00:00","open":14.38,"high":14.5,"low":14.1,"amount":44802200,"amplitude":0.0275,"askPrice":14.13,"askSize":25,"bidPrice":14.12,"bidSize":438,"shortable":0,"etf":0,"ttmEps":0.2976,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"adjPreClose":14.56,"symbolType":"stock","openAndCloseTimeList":[[1789003800000,1789011000000],[1789016400000,1789023600000]],"highLimit":16.02,"lowLimit":13.1,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":263495118,"isCdr":false,"pbRate":2.14,"roa":"--","peRate":47.446237,"roe":"1.35%","epsLYR":0.36,"committee":0.750903,"marketValue":3721000000,"turnoverRate":0.0161,"status":1,"floatMarketCap":2764000000},"requestUrl":"/m/hq/s/300858","defaultTab":"news","newsList":[{"id":"2662337201","title":"科拓生物（300858）2026年中报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2662337201","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662337201?lang=zh_cn&edition=full","pubTime":"2026-08-25 06:07","pubTimestamp":1787609236,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科拓生物发布2026年中报。截至本报告期末，公司营业总收入1.7亿元，同比上升3.77%，归母净利润2509.7万元，同比下降39.09%。本报告期科拓生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达78.4%。管理费用变动幅度为41.01%,原因:本报告期食品板块新工厂建成后增加的管理费用。本文数据来源于科拓生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500009267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224388","title":"8月24日科拓生物跌5.52%，招商均衡配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224388?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:41","pubTimestamp":1787560892,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日科拓生物跌5.52%，收盘报14.55元，换手率3.49%，成交量6.83万手，成交额1.01亿元。重仓科拓生物的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为招商基金的招商均衡配置混合A。招商均衡配置混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661242438","title":"科拓生物2026年半年报：双轮驱动营收增长，增收不增利且现金流承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2661242438","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661242438?lang=zh_cn&edition=full","pubTime":"2026-08-24 10:18","pubTimestamp":1787537908,"startTime":"0","endTime":"0","summary":"财报数据显示，报告期公司实现营业收入1.70亿元，同比增长3.77%；归母净利润2509.70万元，同比下降39.09%；扣非净利润1868.17万元，同比下降46.82%。从业务结构看，食用益生菌制品是核心收入来源，报告期实现营收1.26亿元，同比增长8.99%，毛利率为57.54%；动植物微生态制剂表现亮眼，实现营收3356.17万元，同比增长21.12%；而复配食品添加剂受下游乳制品市场低迷影响，营收仅为928.92万元，同比大幅下降48.97%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787534856091139318","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SPHQ","300858","159399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661100672","title":"图解科拓生物中报：第二季度单季净利润同比下降51.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661100672","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661100672?lang=zh_cn&edition=full","pubTime":"2026-08-23 17:28","pubTimestamp":1787477316,"startTime":"0","endTime":"0","summary":"证券之星消息，科拓生物2026年中报显示，上半年度公司主营收入1.7亿元，同比上升3.77%；归母净利润2509.7万元，同比下降39.09%；扣非净利润1868.17万元，同比下降46.82%；其中2026年第二季度，公司单季度主营收入8450.94万元，同比下降1.43%；单季度归母净利润1014.57万元，同比下降51.4%；单季度扣非净利润621.99万元，同比下降66.31%；负债率11.64%，投资收益405.07万元，财务费用-430.11万元，毛利率47.09%。财报数据概要请见下图:本文数据来源于科拓生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300008500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661210212","title":"科拓生物(300858)6月30日股东户数1.75万户，较上期减少11.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661210212","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661210212?lang=zh_cn&edition=full","pubTime":"2026-08-23 17:07","pubTimestamp":1787476057,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科拓生物披露，截至2026年6月30日公司股东户数为1.75万户，较3月31日减少2241.0户，减幅为11.38%。在化学制品行业个股中，科拓生物股东户数低于行业平均水平，截至6月30日，化学制品行业平均股东户数为2.94万户。从股价来看，2026年3月31日至2026年6月30日，科拓生物区间跌幅为18.46%，在此期间股东户数减少2241.0户，减幅为11.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300008089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453101","title":"科拓生物：关于对巴彦淖尔市圣牧高科生态草业有限公司投资的出资额及性质等具体情况，请关注公司将于2026年8月24日在巨潮资讯网披露的2026年半年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660453101?lang=zh_cn&edition=full","pubTime":"2026-08-18 09:01","pubTimestamp":1787014879,"startTime":"0","endTime":"0","summary":"证券之星消息，科拓生物(300858)08月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司今年上半年对巴彦诺尔市圣牧生态草业有限公司进行投资，请问公司实际出资额是多少？该投资是什么性质的投资科拓生物回复：尊敬的投资者您好，关于对巴彦淖尔市圣牧高科生态草业有限公司投资的出资额及性质等具体情况，请关注公司将于2026年8月24日在巨潮资讯网披露的2026年半年度报告。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800008151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656552708","title":"科拓生物（300858）披露回购公司股份进展公告，8月4日股价上涨0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656552708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656552708?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:42","pubTimestamp":1785854538,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，科拓生物报收于14.23元，较前一交易日上涨0.64%，最新总市值为37.5亿元。该股当日开盘14.14元，最高14.34元，最低14.09元，成交额达4763.68万元，换手率为1.71%。公司于近日披露《关于回购公司股份的进展公告》。公告显示，北京科拓恒通生物技术股份有限公司于2026年4月20日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟用于股权激励或员工持股计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652409816","title":"7月17日科拓生物跌5.21%，工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652409816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652409816?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:57","pubTimestamp":1784278646,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日科拓生物跌5.21%，收盘报14.18元，换手率2.89%，成交量5.67万手，成交额8174.29万元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。工银消费服务混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","000806.SH","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650400519","title":"科拓生物（300858）披露2025年年度权益分派实施后调整回购股份价格上限的公告，7月9日股价下跌1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650400519","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650400519?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:24","pubTimestamp":1783589065,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，科拓生物报收于14.11元，较前一交易日下跌1.4%，最新总市值为37.18亿元。该股当日开盘14.32元，最高14.42元，最低13.76元，成交额达6205.89万元，换手率为2.26%。近日，北京科拓恒通生物技术股份有限公司发布《关于2025年年度权益分派实施后调整回购股份价格上限的公告》。因实施2025年年度权益分派，向全体股东每10股派发现金红利1.00元（含税），按总股本折算每股现金红利为0.0987362元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648686177","title":"科拓生物（300858）披露回购公司股份的进展公告，7月2日股价下跌0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648686177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648686177?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:52","pubTimestamp":1783003936,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，科拓生物报收于15.43元，较前一交易日下跌0.58%，最新总市值为40.66亿元。该股当日开盘15.53元，最高16.05元，最低15.4元，成交额达1亿元，换手率为3.27%。近日，科拓生物披露《关于回购公司股份的进展公告》。公告显示，公司于2026年4月20日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟用于股权激励或员工持股计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647534767","title":"科拓生物（300858）披露回购公司股份比例达到1%的进展公告，6月30日股价下跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647534767?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:01","pubTimestamp":1782813670,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，科拓生物报收于15.19元，较前一交易日下跌0.65%，最新总市值为40.02亿元。该股当日开盘15.28元，最高15.34元，最低14.87元，成交额达9151.57万元，换手率为3.1%。公司于近日披露《关于回购公司股份比例达到1%的进展公告》。公告显示，北京科拓恒通生物技术股份有限公司于2026年4月20日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟用于股权激励或员工持股计划。本次回购符合相关法规及公司既定方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000034119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322157","title":"6月29日科拓生物涨7.37%，工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647322157?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:52","pubTimestamp":1782723173,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日科拓生物涨7.37%，收盘报15.29元，换手率4.96%，成交量9.72万手，成交额1.46亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。工银消费服务混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","000806.SH","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640908784","title":"科拓生物（300858）披露回购公司股份进展公告，6月3日股价下跌0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640908784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640908784?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:44","pubTimestamp":1780479862,"startTime":"0","endTime":"0","summary":"截至2026年6月3日收盘，科拓生物报收于15.73元，较前一交易日下跌0.25%，最新总市值为41.45亿元。该股当日开盘15.77元，最高15.89元，最低15.55元，成交额达6920.25万元，换手率为2.25%。近日，科拓生物发布《关于回购公司股份的进展公告》。公告显示，公司于2026年4月20日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟用于股权激励或员工持股计划。公司将根据市场情况推进回购，并按规定履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640178922","title":"科拓生物：呼和浩特益生菌智慧工厂I期项目投运","url":"https://stock-news.laohu8.com/highlight/detail?id=2640178922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640178922?lang=zh_cn&edition=full","pubTime":"2026-06-03 09:01","pubTimestamp":1780448501,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，请问在呼和浩特益生菌智慧工厂投产之后，现在科拓生物微生态制剂、食用益生菌制品复配食品添加剂的产能分别将达到多少吨/年？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300010204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640592248","title":"科拓生物：公司主营业务为食用益生菌制品、动植物微生态制剂以及复配食品添加剂的研发、生产与销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2640592248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640592248?lang=zh_cn&edition=full","pubTime":"2026-06-03 09:01","pubTimestamp":1780448497,"startTime":"0","endTime":"0","summary":"证券之星消息，科拓生物(300858)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：目前行业内在仲丁基锂连续流规模化生产上已出现明显技术领先企业，该技术直接决定高难度创新药分子的可开发性与商业化效率。请问公司是否掌握相关核心工艺？有无具体项目案例、产能规模及客户验证？若存在明显技术代差，将如何应对高端订单流失的风险？科拓生物回复：尊敬的投资者您好，公司主营业务为食用益生菌制品、动植物微生态制剂以及复配食品添加剂的研发、生产与销售。公司业务不涉及您提及的技术。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300010190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159151","BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640935922","title":"科拓生物：公司益生菌ProSci-246已应用至公司即食型益生菌产品中","url":"https://stock-news.laohu8.com/highlight/detail?id=2640935922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640935922?lang=zh_cn&edition=full","pubTime":"2026-06-03 08:55","pubTimestamp":1780448109,"startTime":"0","endTime":"0","summary":"证券之星消息，科拓生物(300858)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司产品益生菌ProSci-246形成产品上市销售了吗，能披露下销售情况，市场反馈吗？科拓生物回复：尊敬的投资者您好，公司益生菌动物双歧杆菌乳亚种ProSci-246已应用至公司即食型益生菌产品中，相关产品已上市销售。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300010064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637384512","title":"科拓生物（300858）披露2025年年度股东会决议公告，5月21日股价下跌1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637384512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637384512?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:55","pubTimestamp":1779357332,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，科拓生物报收于17.36元，较前一交易日下跌1.14%，最新总市值为45.74亿元。该股当日开盘17.53元，最高17.93元，最低17.24元，成交额达1.79亿元，换手率为5.18%。公司于近日披露《2025年年度股东会决议公告》。同时，会议选举孙天松、刘晓军、乔向前为第四届董事会非独立董事，方芳、鲁绯、李淑彤为第四届董事会独立董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100034558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633943596","title":"5月8日科拓生物涨5.20%，工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633943596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633943596?lang=zh_cn&edition=full","pubTime":"2026-05-08 16:31","pubTimestamp":1778229079,"startTime":"0","endTime":"0","summary":"证券之星消息，5月8日科拓生物涨5.20%，收盘报18.83元，换手率12.97%，成交量25.39万手，成交额4.71亿元。重仓科拓生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。该公募基金现任基金经理为林梦。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800028743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000806.SH","300858","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630171366","title":"4月27日科拓生物跌8.11%，工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630171366","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630171366?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:37","pubTimestamp":1777279054,"startTime":"0","endTime":"0","summary":"证券之星消息，4月27日科拓生物跌8.11%，收盘报19.5元，换手率20.25%，成交量39.63万手，成交额8.1亿元。重仓科拓生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。该公募基金现任基金经理为林梦。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700029574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","000806.SH","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629160798","title":"4月24日科拓生物跌8.34%，工银消费服务混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629160798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629160798?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:37","pubTimestamp":1777019837,"startTime":"0","endTime":"0","summary":"证券之星消息，4月24日科拓生物跌8.34%，收盘报21.22元，换手率19.34%，成交量37.86万手，成交额8.42亿元。重仓科拓生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为工银瑞信基金的工银消费服务混合A。该公募基金现任基金经理为林梦。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400050526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","000806.SH","BK0226"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789038077551,"stockEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":-0.0129},{"period":"3month","weight":-0.0341},{"period":"6month","weight":-0.1299},{"period":"1year","weight":-0.2234},{"period":"ytd","weight":-0.1257}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0038},{"period":"3month","weight":-0.0089},{"period":"6month","weight":-0.0351},{"period":"1year","weight":0.0379},{"period":"ytd","weight":-0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京科拓恒通生物技术股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"17451人(较上一季度减少11.38%)","perCapita":"11216股","listingDate":"2020-07-27","address":"北京市怀柔区雁栖经济开发区牤牛河路31号院1号-2","registeredCapital":"26349万元","survey":" 北京科拓恒通生物技术股份有限公司的主营业务是食用益生菌制品、动植物微生态制剂以及复配食品添加剂研发、生产与销售。公司的主要产品是食用益生菌制品、动植物微生态制剂、复配食品添加剂。公司参与的《优良乳酸菌种质资源挖掘与产业化关键技术创制及应用》项目，荣获2023年度国家科学技术进步奖二等奖。","listedPrice":23.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科拓生物(300858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科拓生物(300858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科拓生物,300858,科拓生物股票,科拓生物股票老虎,科拓生物股票老虎国际,科拓生物行情,科拓生物股票行情,科拓生物股价,科拓生物股市,科拓生物股票价格,科拓生物股票交易,科拓生物股票购买,科拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科拓生物(300858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科拓生物(300858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}